|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.97 EUR | -1.98% |
|
-1.00% | -20.59% |
| Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
| Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
Heidelberg Pharma AG reported earnings results for the full year ended November 30, 2022. For the full year, the company reported sales was EUR 18.51 million compared to EUR 1.75 million a year ago. Revenue was EUR 19.86 million compared to EUR 2.31 million a year ago.
Net loss was EUR 19.7 million compared to EUR 26.14 million a year ago. Basic loss per share from continuing operations was EUR 0.53 compared to EUR 0.8 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.59% | 148M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
HEIDELBERG PHARMA AG 
